A single-center, double-blinded, randomized, and placebo-controlled clinic trial on Yangxuetongmai Formula in the treatment of primary hypotension

Authors
Category Primary study
Registry of TrialsITMCTR
Year 2024
INTERVENTION: Control group:Placebo;Treatment group:Yangxuetongmai Formula; CONDITION: Primary Hypotension PRIMARY OUTCOME: Blood pressure ; SECONDARY OUTCOME: Fatigue Severity Scale (FSS) score;Scoring of Four Diagnostic Information of Traditional Chinese Medicine;SF‐36 Quality of Life score; INCLUSION CRITERIA: (1) Aged 16 to 75 years, gender is not limited; (2) Meets the diagnostic standard of primary hypotension; (3) Volunteer to participate in the clinical trial, understand and sign the informed consent.
Epistemonikos ID: 27fb9873d7c1807e84f447d0d58bc5039d205d98
First added on: Feb 24, 2025